CRP/ALB比值及SIL对吉兰-巴雷综合征患者呼吸衰竭的预测价值

doi:10.3760/cma.j.issn.1007-1245.2023.18.015

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (18): 2580-2584.DOI: 10.3760/cma.j.issn.1007-1245.2023.18.015

CRP/ALB比值及SIL对吉兰-巴雷综合征患者呼吸衰竭的预测价值

白成芳常钦达

聊城市第三人民医院神经内科，聊城　252000

收稿日期:2023-01-08 出版日期:2023-09-15 发布日期:2023-09-25
通讯作者: 白成芳，Email：chen66jl@163.com
基金资助:
2019年度山东省医药卫生科技发展计划项目（2019WS336）

Predictive value of C-reactive protein/albumin ratio and systemic immune inflammatory index for respiratory failure in patients with Guillain-Barré syndrome

Bai Chengfang, Chang Qinda

Department of Neurology, Liaocheng Third People's Hospital, Liaocheng 252000, China

Received:2023-01-08 Online:2023-09-15 Published:2023-09-25
Contact: Bai Chengfang, Email: chen66jl@163.com
Supported by:
Project of Developmental Plan of Medical and Health Science and Technology in Shandong in 2019 (2019WS336)

摘要/Abstract

摘要：

目的　探讨C-反应蛋白（CRP）/白蛋白（ALB）比值及系统免疫炎症指数（SII）对吉兰-巴雷综合征（GBS）患者呼吸衰竭的预测价值。方法　采用回顾性分析，选取2018年5月至2022年5月期间聊城市第三人民医院收治的108例GBS患者作为研究对象，其中，男69例，女39例，年龄（52.15±12.46）岁；根据患者将住院期间是否出现呼吸衰竭将其分为呼吸衰竭组（25例）和单纯GBS组（83例），比较两组患者入院修斯功能分级量表（HFGS）评分等一般临床资料，入院时CRP/ALB比值和SII。采用t、χ²检验，并采用受试者工作特征曲线（ROC）分析二者联合检测对GBS患者发生呼吸衰竭的预测价值。结果　呼吸衰竭组患者入院时的CRP/ALB比值和SII分别为（3.05±0.35）×10^-3、（1 453.87±142.65）×10⁹/I，均明显高于单纯GBS组［（2.45±0.31）×10^-3、（392.75±35.53）×10⁹/I］，差异均有统计学意义（均P<0.05）；ROC分析结果显示，CRP/ALB和SII联合预测GBS患者发生呼吸衰竭的ROC曲线下面积明显比两项指标单独预测更高（P<0.05）。呼吸衰竭组和单纯GBS组在入院时HFGS评分、有无脑神经受累、入院时CRP/ALB比值和SII方面差异均有统计学意义（均P<0.05）；多因素logistic分析结果显示，HFGS≥3分、CRP/ALB≥2.85×10^-3和SII≥870.52×10⁹/I是GBS患者出现呼吸衰竭的重要影响因素。结论　CRP/ALB比值和SII联合检测对于GBS患者呼吸衰竭具有较高的预测价值。

关键词:

吉兰-巴雷综合征, 呼吸衰竭, C-反应蛋白/白蛋白比值, 系统免疫炎症指数

Abstract:

Objective　To investigate the value of C-reactive protein (CRP)/albumin (ALB) ratio and systemic immune inflammatory index (SII) in the prediction of respiratory failure in patients with Guillain-Barré syndrome (GBS). Methods　A total of 108 patients with GBS who were admitted to Liaocheng Third People's Hospital from May 2018 to May 2022 were selected for the retrospective analysis, including 69 males and 39 females who were (52.15±12.46) years old. They were divided into a respiratory failure group (25 cases) and a pure GBS group (83 cases) according to whether they had respiratory failure during hospitalization. The general clinical data, such as Hughes Functional Classification Scale (HFGS) score at admission and so on, and CRP/ALB and SII at admission were compared between the two groups. t and χ² tests were applied, the combined detection of the two in the prediction of respiratory failure in the GBS patients was analyzed by the receiver operating characteristic curve (ROC). Results　The CRP/ALB and SII at admission in the respiratory failure group were significantly higher than those in the pure GBS group [(3.05±0.35)×10^-3 vs. (2.45±0.31)×10^-3 and (1 453.87±142.65)×10⁹/I vs. (392.75±35.53)×10⁹/I], with statistical differences (both P<0.05). The ROC analysis showed that the area under the ROC of CRP/ALB combined with SII in the prediction of respiratory failure in the GBS patients was higher than those under the ROC's of CRP/ALB and SII (P<0.05). There were statistical differences in HFGS score at admission, cranial nerve involvement, and CRP/ALB and SII at admission between the respiratory failure group and the pure GBS group (all P<0.05). Multivariate logistic analysis showed that HFGS≥3, CRP/ALB ≥ 2.85×10^-3, and SII≥870.52×10⁹/I were important influencing factors for respiratory failure in the GBS patients. Conclusion　The combined detection of CRP/ALB and SII has a high predictive value for respiratory failure in GBS patients.

Key words:

Guillain-Barré syndrome, Respiratory failure, C-reactive protein/albumin ratio, Systemic immune inflammatory index

白成芳常钦达.

CRP/ALB比值及SIL对吉兰-巴雷综合征患者呼吸衰竭的预测价值 [J]. 国际医药卫生导报, 2023, 29(18): 2580-2584.

Bai Chengfang, Chang Qinda.

Predictive value of C-reactive protein/albumin ratio and systemic immune inflammatory index for respiratory failure in patients with Guillain-Barré syndrome [J]. International Medicine and Health Guidance News, 2023, 29(18): 2580-2584.

参考文献

[1] 李胜,刘美辰,刘馨遥.EGRIS 模型预测 Guillain-Barré综合征患者呼吸衰竭风险的初步研究[J].临床神经病学杂志,2019,32(2):104-107.DOI:10.3969/j.issn.1004-1648. 2019.02.014.
[2] 孙振康,刘成,尤青海.肺损伤预测评分对重症患者急性呼吸衰竭风险的预测价值[J].安徽医学,2019,40(9):971-974.DOI:10.3969/j.issn.1000-0399.2019.09.003.
[3] 张辉,施仲义,胡一迪,等.术前系统免疫炎症指数和反应蛋白/血清白蛋白比值与非小细胞肺癌预后的相关性[J].中国卫生检验杂志,2019,29(5):573-576.
[4] 王铎颖,郭栋,滕菲菲,等.系统免疫炎症指数对小细胞肺癌预防性脑照射患者脑转移和生存预测价值[J].中华肿瘤防治杂志,2019,26(19):1473-1478.DOI:10.16073/j.cnki.cjcpt. 2019.19.12.
[5] 中华医学会神经病学分会神经肌肉病学组,中华医学会神经病学分会肌电图及临床神经电生理学组,中华医学会神经病学分会神经免疫学组.中国吉兰-巴雷综合征诊治指南[J].中华神经科杂志,2010,43(8):583-586.DOI:10.3760/cma.j.issn.1006-7876.2010.08.018.
[6] 朱元珏.急性呼吸衰竭的诊断与治疗[J].中华内科杂志,1993,32(9):621-626.
[7] 吴章薇,周昊,赵圣杰,等.重型吉兰-巴雷综合征合并呼吸衰竭患者临床危险因素和长期预后分析[J].中国神经免疫学和神经病学杂志,2017,24(1):38-43.DOI:10.3969/j.issn.1006-2963.2017.01-010.
[8] Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps[J]. Nat Rev Neurol, 2019,15(11):671-683. DOI: 10.1038/s41582-019-0250-9.
[9] 刘美辰,李胜.吉兰-巴雷综合征患者呼吸衰竭的早期预测因素的研究进展[J].中华神经医学杂志,2017,16(2):214-216.DOI:10.3760/cma.j.issn.1671-8925.2017.02.023.
[10] 张宁,刘文娴,康云鹏.血浆超敏C-反应蛋白与白蛋白比值对急性冠脉综合征患者死亡的预测价值[J].中华危重病急救医学,2021,33(5):573-577.DOI:10.3760/cma.j.cn121430-20201127-00736.
[11] 郑伟钢,蒋文芳.C-反应蛋白与血清白蛋白比值预测感染性休克患者发生急性呼吸窘迫综合征的价值分析[J].解放军预防医学杂志,2019,37(06):24-25.DOI:10.13704/j.cnki.jyyx.2019.06.011.
[12] 谈燚,尹宏祥,段家康,等.系统免疫炎症指数对Child-Pugh B级肝细胞癌术后预后预测价值[J].沈阳医学院学报,2022,24(2):118-122,127.
[13] 代焕,朱正秋,陈嘉劼.系统免疫炎症指数、预后营养指数对Ⅲ～Ⅳ期非小细胞肺癌一线化疗患者预后的预测价值[J].医学研究杂志,2022,51(3):121-126.DOI:10.11969/j.issn.1673-548X.2022.03.027.
[14] Ceylan M, Sonkaya A. The investigation of guillain-barre syndrome and prognosis[J]. Annals of Medical Research,2019,26(4):763-768. DOI:10.5455/annalsmedres. 2019.02.102

CRP/ALB比值及SIL对吉兰-巴雷综合征患者呼吸衰竭的预测价值

Predictive value of C-reactive protein/albumin ratio and systemic immune inflammatory index for respiratory failure in patients with Guillain-Barré syndrome

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	路秀芳田金静康亚丽. 相关生化指标在AECOPD伴呼吸衰竭患者中的水平变化及临床意义分析 [J]. 国际医药卫生导报, 2023, 29(8): 1131-1134.
[2]	袁法伟李炳奇. 体外膜肺氧合治疗呼吸衰竭的效果及预后分析 [J]. 国际医药卫生导报, 2023, 29(7): 973-977.
[3]	吴莹莹江成养郭卫东郭艳芬. 无创正压通气联合洛贝林治疗COPD合并呼吸衰竭的疗效观察[J]. 国际医药卫生导报, 2022, 28(16): 2272-2275.
[4]	袁法伟, 冯辉斌, 尹欢, 郑鲲, 梅喜平, 袁利学, 祝小梅. 呼吸衰竭患者体外膜肺氧合治疗后心率、氧合指数改变及APACHEⅡ与SOFA评分对预后的预测价值[J]. 国际医药卫生导报, 2022, 28(10): 1338-1342.